201 related articles for article (PubMed ID: 2502567)
41. [Effectiveness of fusidic acid alone and in combination with hydrocortisone-17-butyrate in infected dermatoses].
Enderer K; Höffler U
Z Hautkr; 1984 Feb; 59(3):151-4. PubMed ID: 6719973
[TBL] [Abstract][Full Text] [Related]
42. Trimethoprim-polymyxin B sulphate cream compared with fusidic acid cream in the treatment of superficial bacterial infection of the skin.
el Mofty M; Harvey SG; Gibson JR; Calthrop JG; Marks P
J Int Med Res; 1990; 18(2):89-93. PubMed ID: 2160379
[TBL] [Abstract][Full Text] [Related]
43. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy.
Mertz PM; Marshall DA; Eaglstein WH; Piovanetti Y; Montalvo J
Arch Dermatol; 1989 Aug; 125(8):1069-73. PubMed ID: 2502950
[TBL] [Abstract][Full Text] [Related]
44. [Fucidin ointment in treatment of staphylococcal infections].
Kjelstrup Y
Tidsskr Nor Laegeforen; 1968 Nov; 88(21):2031-5. PubMed ID: 5724697
[No Abstract] [Full Text] [Related]
45. [Sodium fucidin treatment of pustular skin diseases].
Levkovskiĭ NM; Golovchenko DIa; Fedorenko AE
Feldsher Akush; 1980; 45(11):21-2. PubMed ID: 6906270
[No Abstract] [Full Text] [Related]
46. The clinical efficacy of topical and systemic therapy for the treatment of feline ocular chlamydiosis.
Sparkes AH; Caney SM; Sturgess CP; Gruffydd-Jones TJ
J Feline Med Surg; 1999 Mar; 1(1):31-5. PubMed ID: 11919013
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat.
Yasim A; Gul M; Atahan E; Ciragil P; Aral M; Ergun Y
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):274-9. PubMed ID: 16360328
[TBL] [Abstract][Full Text] [Related]
48. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients.
Boelaert JR; De Smedt RA; De Baere YA; Godard CA; Matthys EG; Schurgers ML; Daneels RF; Gordts BZ; Van Landuyt HW
Nephrol Dial Transplant; 1989; 4(4):278-81. PubMed ID: 2502734
[TBL] [Abstract][Full Text] [Related]
49. The safety record of fusidic acid in non-US markets: a focus on skin infections.
Kraus CN; Burnstead BW
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S527-37. PubMed ID: 21546630
[TBL] [Abstract][Full Text] [Related]
50. A prospective, randomized pilot evaluation of topical triple antibiotic versus mupirocin for the prevention of uncomplicated soft tissue wound infection.
Hood R; Shermock KM; Emerman C
Am J Emerg Med; 2004 Jan; 22(1):1-3. PubMed ID: 14724869
[TBL] [Abstract][Full Text] [Related]
51. Fusidic acid in skin infections and infected atopic eczema.
Bonamonte D; Belloni Fortina A; Neri L; Patrizi A
G Ital Dermatol Venereol; 2014 Aug; 149(4):453-9. PubMed ID: 25068235
[TBL] [Abstract][Full Text] [Related]
52. In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets.
Loeffler A; Baines SJ; Toleman MS; Felmingham D; Milsom SK; Edwards EA; Lloyd DH
J Antimicrob Chemother; 2008 Dec; 62(6):1301-4. PubMed ID: 18819974
[TBL] [Abstract][Full Text] [Related]
53. Impetigo contagiosa III. Comparative efficacy of oral erythromycin and topical mupirocin.
Barton LL; Friedman AD; Sharkey AM; Schneller DJ; Swierkosz EM
Pediatr Dermatol; 1989 Jun; 6(2):134-8. PubMed ID: 2501775
[TBL] [Abstract][Full Text] [Related]
54. Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops.
Jackson WB; Low DE; Dattani D; Whitsitt PF; Leeder RG; MacDougall R
Can J Ophthalmol; 2002 Jun; 37(4):228-37; discussion 237. PubMed ID: 12095096
[TBL] [Abstract][Full Text] [Related]
55. Topical Bactroban (mupirocin): efficacy in treating burn wounds infected with methicillin-resistant staphylococci.
Strock LL; Lee MM; Rutan RL; Desai MH; Robson MC; Herndon DN; Heggers JP
J Burn Care Rehabil; 1990; 11(5):454-9. PubMed ID: 2123203
[TBL] [Abstract][Full Text] [Related]
56. Mupirocin: a new topical therapy for impetigo.
Putnam CD; Reynolds MS
J Pediatr Health Care; 1989; 3(4):224-7. PubMed ID: 2502615
[TBL] [Abstract][Full Text] [Related]
57. Topical mupirocin vs. systemic erythromycin treatment for pyoderma.
McLinn S
Pediatr Infect Dis J; 1988 Nov; 7(11):785-90. PubMed ID: 3148127
[TBL] [Abstract][Full Text] [Related]
58. An open study of mupirocin in Libyan patients with skin infections.
El Ferghani N
J Int Med Res; 1995; 23(6):508-17. PubMed ID: 8746621
[TBL] [Abstract][Full Text] [Related]
59. Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo.
Goldfarb J; Crenshaw D; O'Horo J; Lemon E; Blumer JL
Antimicrob Agents Chemother; 1988 Dec; 32(12):1780-3. PubMed ID: 3149884
[TBL] [Abstract][Full Text] [Related]
60. Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - a randomized double blind pilot trial.
Canpolat F; Erkoçoğlu M; Tezer H; Kocabaş CN; Kandi B
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1989-93. PubMed ID: 23242727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
